Blood basophils in lung cancer

Area of Science:

• Oncology
• Immunology
• Hematology

Background:

• Basophils play a role in immune responses.
• Altered immune cell counts are observed in various cancers.
• Understanding peripheral blood cell profiles can aid in cancer diagnosis and prognosis.

Purpose of the Study:

• To investigate peripheral blood basophil counts in patients with primary bronchial carcinoma.
• To compare basophil levels between lung cancer patients, other chest condition patients, and healthy individuals.
• To explore the relationship between basophil counts and tumor characteristics, including resectability.

Main Methods:

• Peripheral blood basophils were quantified using thick smear analysis.
• Samples were collected from patients with primary bronchial carcinoma, other chest conditions, and normal controls.
• Statistical analysis was performed to compare median counts and assess correlations.

Main Results:

• Tumor-bearing patients exhibited significantly higher median basophil counts (33/microliter) compared to normal individuals (19/microliter) and those with other chest conditions (15.5/microliter).
• Patients with squamous bronchial carcinoma showed the highest basophil levels, suggesting an anti-tumor immune response.
• Elevated lymphocyte and basophil counts at diagnosis were associated with improved surgical resectability.

Conclusions:

• Elevated peripheral blood basophil counts are indicative of bronchial carcinoma.
• Squamous cell carcinoma is associated with the highest basophil levels, potentially reflecting an active immune response.
• Basophil and lymphocyte counts may serve as prognostic markers for surgical resectability in lung cancer.